Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMacrogenics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.76 | -$0.21 | -$0.57 |
| Q2 2026 | 3 | -$0.01 | $0.05 | $0.03 |
| Q3 2026 | 3 | -$2.32 | $1.15 | -$0.34 |
| Q4 2026 | 1 | -$0.46 | $0.01 | -$0.18 |
| Q1 2027 | 1 | -$0.98 | $0.02 | -$0.38 |
| Q2 2027 | 1 | -$1.09 | $0.02 | -$0.43 |
| Q3 2027 | 1 | -$0.87 | $0.02 | -$0.34 |
| Q4 2027 | 1 | -$0.87 | $0.02 | -$0.34 |
Macrogenics Inc Earnings Date And Information
Macrogenics Inc last posted its earnings results on Wednesday, May 13th, 2026. The company reported $-0.58 earnings per share for the quarter, missing analysts' consensus estimates of $-0.57 by $0.01. The company had revenue of 20.78 M for the quarter and had revenue of 149.50 M for the year. Macrogenics Inc has generated $-1 earnings per share over the last year ($-1.18 diluted earnings per share) and currently has a price-to-earnings ratio of -4.41. Macrogenics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Macrogenics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2026 | Q1 2026 | -$0.57 | -$0.58 | -0.01 | $15.24 M | $20.78 M |
| 03/09/2026 | Q4 2025 | -$0.42 | -$0.22 | 0.2 | $34.59 M | $41.23 M |
| 11/12/2025 | Q3 2025 | -$0.48 | $0.27 | 0.75 | $25.60 M | $72.84 M |
| 08/14/2025 | Q2 2025 | -$0.59 | -$0.57 | 0.02 | $31.67 M | $22.24 M |
| 05/13/2025 | Q1 2025 | -$0.61 | -$0.65 | -0.04 | $9.59 M | $13.19 M |
| 03/20/2025 | Q4 2024 | -$0.23 | -$0.25 | -0.02 | $35.71 M | $17.73 M |
| 11/05/2024 | Q3 2024 | $0.21 | $0.90 | 0.69 | $87.61 M | $110.71 M |
| 08/06/2024 | Q2 2024 | -$0.59 | -$0.89 | -0.3 | $20.94 M | $10.80 M |
| 05/09/2024 | Q1 2024 | -$0.67 | -$0.84 | -0.17 | $14.86 M | $9.10 M |
| 03/07/2024 | Q4 2023 | -$0.26 | -$0.74 | -0.48 | N/A | $10.72 M |
| 11/06/2023 | Q3 2023 | -$0.11 | $0.28 | 0.39 | N/A | $10.40 M |
| 08/09/2023 | Q2 2023 | -$0.52 | $0.93 | 1.45 | N/A | $13.14 M |
| 05/09/2023 | Q1 2023 | $1.07 | -$0.62 | -1.69 | N/A | $24.50 M |
| 03/15/2023 | Q4 2022 | $0.10 | $0.21 | 0.11 | N/A | $73.10 M |
| 11/03/2022 | Q3 2022 | -$0.49 | -$0.40 | 0.09 | N/A | $41.73 M |
| 08/08/2022 | Q2 2022 | -$0.97 | -$0.67 | 0.3 | N/A | $26.01 M |
| 05/03/2022 | Q1 2022 | -$0.84 | -$1.08 | -0.24 | N/A | $10.67 M |
| 02/24/2022 | Q4 2021 | -$0.83 | -$0.95 | -0.12 | N/A | $14.15 M |
| 11/02/2021 | Q3 2021 | -$0.63 | -$0.86 | -0.23 | N/A | $15.66 M |
| 07/29/2021 | Q2 2021 | -$0.28 | -$0.66 | -0.38 | N/A | $30.76 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Macrogenics Inc Earnings: FAQ's
The conference call for Macrogenics Inc's latest earnings report can be listened to online.
The conference call transcript for Macrogenics Inc's latest earnings report can be read online.
Macrogenics Inc (:MGNX) has a recorded annual revenue of $149.50 M.
Macrogenics Inc (:MGNX) has a recorded net income of $-74,620,000.Macrogenics Inc has generated $-1.18 earnings per share over the last four quarters.
Macrogenics Inc (:MGNX) has a price-to-earnings ratio of -4.41 and price/earnings-to-growth ratio is 0.04.